Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun;51(4):101164.
doi: 10.1016/j.neurad.2023.10.009. Epub 2023 Oct 30.

Multimodal assessment of brain fluid clearance is associated with amyloid-beta deposition in humans

Affiliations

Multimodal assessment of brain fluid clearance is associated with amyloid-beta deposition in humans

Liangdong Zhou et al. J Neuroradiol. 2024 Jun.

Abstract

Purpose: The present study investigates a multimodal imaging assessment of glymphatic function and its association with brain amyloid-beta deposition.

Methods: Two brain CSF clearance measures (vCSF and DTI-ALPS) were derived from dynamic PET and MR diffusion tensor imaging (DTI) for 50 subjects, 24/50 were Aβ positive (Aβ+). T1W, T2W, DTI, T2FLAIR, and 11C-PiB and 18F-MK-6240 PET were acquired. Multivariate linear regression models were assessed with both vCSF and DTI-ALPS as independent variables and brain Aβ as the dependent variable. Three types of models were evaluated, including the vCSF-only model, the ALPS-only model and the vCSF+ALPS combined model. Models were applied to the whole group, and Aβ subgroups. All analyses were controlled for age, gender, and intracranial volume.

Results: Sample demographics (N=50) include 20 males and 30 females with a mean age of 69.30 (sd=8.55). Our results show that the combination of vCSF and ALPS associates with Aβ deposition (p < 0.05, R2 = 0.575) better than either vCSF (p < 0.05, R2 = 0.431) or ALPS (p < 0.05, R2 = 0.372) alone in the Aβ+ group. We observed similar results in whole-group analyses (combined model: p < 0.05, R2 = 0.287; vCSF model: p <0.05, R2 = 0.175; ALPS model: p < 0.05, R2 = 0.196) with less significance. Our data also showed that vCSF has higher correlation (r = -0.548) in subjects with mild Aβ deposition and DTI-ALPS has higher correlation (r=-0.451) with severe Aβ deposition subjects.

Conclusion: The regression model with both vCSF and DTI-ALPS is better associated with brain Aβ deposition. These two independent brain clearance measures may better explain the variation in Aβ deposition than either term individually. Our results suggest that vCSF and DTI-ALPS reflect complementary aspects of brain clearance functions.

Keywords: (11)C-PiB PET; (18)F-MK-6240 PET; Alzheimer's disease; Brain clearance; CSF turnover rate vCSF; DTI-ALPS; Multimodal analysis.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors have no competing interests to declare.

Figures

Figure 1
Figure 1
Flowchart of participants finalization.
Figure 2
Figure 2
Illustration of dynamic 18F-MK6240 in the brain and formulation for calculation of vCSF using TAC in lateral ventricle and area under curve (AUC) of whole brain (WB) TAC.
Figure 3
Figure 3
Illustration of ROIs on (A) color-coded FA for DTI-ALPS, white matter fiber directions and (B) the medullary veins on SWI.
Figure 4
Figure 4
The positive correlation between DTI-ALPS and vCSF. The correlation between them is the strongest in the Aβ+ group.
Figure 5
Figure 5
In whole group, partial regression plot of significant variables versus Aβ deposit in AD mask in vCSF+ALPS model. (A) vCSF; (B) ALPS; and (C) ALPS*vCSF.
Figure 6
Figure 6
In Aβ positive group, partial regression plot of significant variables versus Aβ deposit in AD mask in vCSF+ALPS model. (A) vCSF; (B) ALPS; (C) ALPS*vCSF; and (D) Sex.
Figure 7
Figure 7
In Aβ negative group, partial regression plot of significant variable (Age) versus Aβ deposit measured in AD mask in (A) vCSF+ALPS model, (B) vCSF model; and (C) ALPS model.

References

    1. Hladky SB, Barrand MA. Elimination of substances from the brain parenchyma: efflux via perivascular pathways and via the blood–brain barrier. Fluids and Barriers of the CNS. 2018;15(1):30. doi: 10.1186/s12987-018-0113-6 - DOI - PMC - PubMed
    1. Abbott NJ, Pizzo ME, Preston JE, Janigro D, Thorne RG. The role of brain barriers in fluid movement in the CNS: is there a “glymphatic” system? Acta Neuropathol. 2018;135(3):387–407. doi: 10.1007/s00401-018-1812-4 - DOI - PubMed
    1. Bakker ENTP, Bacskai BJ, Arbel-Ornath M, et al. Lymphatic Clearance of the Brain: Perivascular, Paravascular and Significance for Neurodegenerative Diseases. Cell Mol Neurobiol. 2016;36(2):181–194. doi: 10.1007/s10571-015-0273-8 - DOI - PMC - PubMed
    1. Louveau A, Plog BA, Antila S, Alitalo K, Nedergaard M, Kipnis J. Understanding the functions and relationships of the glymphatic system and meningeal lymphatics. J Clin Invest. 2017;127(9):3210–3219. doi: 10.1172/JCI90603 - DOI - PMC - PubMed
    1. Mestre H, Mori Y, Nedergaard M. The Brain’s Glymphatic System: Current Controversies. Trends Neurosci. 2020;43(7):458–466. doi: 10.1016/j.tins.2020.04.003 - DOI - PMC - PubMed

Substances

LinkOut - more resources